Surgery for Early-Stage NSCLC Yields Similar Outcomes in Octogenarians, Younger Patients

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

FRIDAY, April 10, 2026 -- Surgical treatment for early-stage non-small cell lung cancer (NSCLC) is associated with similarly favorable safety and long-term outcomes for octogenarians and for younger patients, according to a study published in the April issue of The Lancet Regional Health: Americas.

Louis Gros, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues compared postoperative outcomes, survival, and quality of life (QoL) between octogenarians (80 years and older) and younger patients undergoing surgery for stage IA NSCLC. Physical and mental health scores assessed at baseline and at one, six, and 12 months after surgery were used to measure QoL.

Overall, 114 (12.9 percent) of the 884 patients were octogenarians. The researchers found that octogenarians had similar comorbidities compared with younger patients but more often underwent sublobar resections (78.9 versus 62.4 percent) and had higher complication rates (40 versus 22 percent), especially cardiovascular complications. Octogenarians had slightly more intensive care unit admissions and readmissions. Physical and mental health declined at two months but improved by 12 months in both age groups, with no significant differences. Octogenarians and younger patients had similar five-year overall and lung cancer-specific survival rates (overall: 84.2 versus 87.3 percent; lung cancer-specific: 94.4 versus 94.5 percent).

"When lung cancer is found at an early stage, patients (even those over 80) can benefit from treatments that offer a real chance at a cure," lead author Claudia I. Henschke, M.D., Ph.D., also from the Icahn School of Medicine, said in a statement. "This study shows that with the right approach, we can extend both life and quality of life for older adults."

Two authors disclosed ties to industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-11 01:45

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords